Year |
Citation |
Score |
2006 |
Hebert ML, Grimm D, Storm TA, Kay MA. 489. Treatment for Hemophilia B Using Self- Complimentary AAV8 Vectors Molecular Therapy. 13: S189-S190. DOI: 10.1016/J.Ymthe.2006.08.559 |
0.316 |
|
2006 |
Grimm D, Streetz KL, Storm TA, Jopling CL, Lee JS, Kay MA. 805. Fatality in Mice Due to Oversaturation of Cellular Micro/Short Hairpin RNA Pathways Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.1226 |
0.309 |
|
2005 |
Ehrhardt A, Kay MA. Gutted adenovirus: a rising star on the horizon? Gene Therapy. 12: 1540-1. PMID 18360947 DOI: 10.1038/Sj.Gt.3302597 |
0.312 |
|
2005 |
Grimm D, Pandey K, Streetz KL, Kay MA. 857. A Versatile and Efficient Viral Vector Platform for Stable In Vivo Expression of Short Hairpin RNA Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.400 |
0.312 |
|
2005 |
Grimm D, Streetz KL, Pandey K, Storm TA, Kay MA. 87. Determinants of Toxicity Induced by In Vivo Expression of Short Hairpin RNA from AAV Vectors Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.065 |
0.31 |
|
2005 |
Mikkelsen JG, Yant SR, Ehrhardt A, Kay MA. 22. Generation of Circular Sleeping Beauty DNA Transposition Substrates by RU486-Induced Flp Recombination In Vitro |[ndash]| Steps towards a Single Integrating Adeno-Transposon Vector Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.025 |
0.306 |
|
2004 |
Riu E, Huang Z, Kay MA. 1039. Mechanistic Insights into the Persistence of Non-Viral Mediated Gene Transfer In Vivo Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.984 |
0.305 |
|
2003 |
Mikkelsen JG, Yant SR, Meuse L, Huang Z, Xu H, Kay MA. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 654-65. PMID 14529839 DOI: 10.1016/S1525-0016(03)00216-8 |
0.304 |
|
2003 |
Sclimenti CR, Neviaser AS, Baba EJ, Meuse L, Kay MA, Calos MP. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice Biotechnology Progress. 19: 144-151. PMID 12573017 DOI: 10.1021/Bp0200907 |
0.323 |
|
2002 |
Yant SR, Ehrhardt A, Mikkelsen JG, Meuse L, Pham T, Kay MA. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nature Biotechnology. 20: 999-1005. PMID 12244327 DOI: 10.1038/Nbt738 |
0.317 |
|
2001 |
Stoll SM, Sclimenti CR, Baba EJ, Meuse L, Kay MA, Calos MP. Epstein-Barr virus/human vector provides high-level, long-term expression of α1-antitrypsin in mice Molecular Therapy. 4: 122-129. PMID 11482983 DOI: 10.1006/Mthe.2001.0429 |
0.303 |
|
2000 |
Nakai H, Storm TA, Kay MA. Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors Nature Biotechnology. 18: 527-532. PMID 10802620 DOI: 10.1038/75390 |
0.301 |
|
2000 |
Miao CH, Nakai H, Thompson AR, Storm TA, Chiu W, Snyder RO, Kay MA. Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction. Journal of Virology. 74: 3793-803. PMID 10729154 DOI: 10.1128/Jvi.74.8.3793-3803.2000 |
0.318 |
|
1998 |
Patijn GA, Lieber A, Meuse L, Winther B, Kay MA. High-efficiency retrovirus-mediated gene transfer into the livers of mice. Human Gene Therapy. 9: 1449-56. PMID 9681416 DOI: 10.1089/Hum.1998.9.10-1449 |
0.311 |
|
Show low-probability matches. |